2,3,4-Trihydroxybenzaldehyde

We are 2,3,4-Trihydroxybenzaldehyde CAS:2144-08-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Synonyms:
Pyrogallol-4-carboxaldehyde
EINECS 218-404-2
2,3,4-trishydroxybenzaldehyde
2,3,4-trihydroxy benzaldehyde
protocataculaldehyde
Benzaldehyde,2,3,4-trihydroxy
Benzaldehyde, 2,3,4-trihydroxy-
2,3,4,5,6-PENTAFLUOROPHENYL 4-BROMO-2-CHLOROBENZENESULPHONATE
2,3,4-Trihydroxy-benzaldehyd
 
Molecular Formula: C7H6O4
Molecular Weight: 154.12000

Appearance and properties: light yellow needle-like crystals (water). m.p.161-162℃, irritating.
Density: 1.598 g/cm3
Boiling point: 301.9ºC at 760 mmHg
Melting point: 159-161 °C(lit.)
Flash point: 112ºC
Refractive index: 1.734
 
Stability: Stable under normal temperatures and pressures.
Storage conditions: Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Items of Analysis Standard of Analysis Test Results
Appearance Light yellow crystalline powder Light yellow crystalline powder
Assay ≥99.5% 99.75%
Loss on Drying ≤0.2% 0.15%
Melting point 161℃~163℃ 161℃~162℃
Residue on ignition ≤0.1% 0.03%
Heavy metal ≤20ppm <20ppm
As ≤3ppm <3ppm
Pb ≤2ppm <2ppm
Conclusion Conforms to Factory Standard
 

 

2,3,4-Trihydroxybenzaldehyde


Related News: Inceptua Medicines Access is a business unit of the Inceptua Group. It offers full access solutions for the design, implementation and delivery of Pre-approval and Medicines Access Programs on behalf of biopharmaceutical companies.1,6-Bis-(pentachlorphenyl)-hexandion-(1,6) Inceptua Medicines Access is a business unit of the Inceptua Group. It offers full access solutions for the design, implementation and delivery of Pre-approval and Medicines Access Programs on behalf of biopharmaceutical companies.(Z)-2-(5-bromo-2,3,3,4,4,5,5-heptafluoropent-1-en-1-yl)-1,3-oxathiolane Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK.2,3,4-Trifluoroaniline With the improvement of people’s living standards and the aging degree, the demand for medicines has been increasing for a long time. Therefore, the transfer from finished medicines to bulk medicines has greatly promoted the demand for bulk medicines.The novel coronavirus has resulted in thousands of confirmed human infections in more than 20 countries, with more than 99 percent of cases in China.

Related Products
Product Name
5-(2-Fluorophenyl)-1H-pyrrole-3-carboxaldehyde View Details
4-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine View Details
2,3-Dimethoxypyridine View Details
(1S,4R)-Methyl 4-((tert-butoxycarbonyl)amino)cyclopent-2-enecarboxylate manufacturer 2-(3,5-dibromophenyl)-4,6-diphenyl-1,3,5-triazine manufacturer 2-Chloro-3-fluoro-4-methylpyridine manufacturer Methyl 4-(2-methoxy-2-oxoethyl)-3-nitrobenzoate manufacturer N,N-dimethylformamide manufacturer